CAMAISA ALLAN (CEO, President and Chairman) sold 13.0% of their position (10K shares) of CALIDI BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $16.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2024ACC: 0001493152-24-050675
DirectorOfficer10% Owner· CEO, President and Chairman
Since Sep 2023
-10K
Net shares
Net seller
$16.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$1.62
Trade value
$16.20K
% of position
13.0%
12/17/2024
76.71K→66.71K
Total
Net shares
−10K
Net value
-$16.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2024 | S · Sale | −10K | $1.62 | $16.20K | 13.0% | 76.71K | 66.71K |
| Total | −10K | -$16.20K | ||||||
Derivative Transactions0
No derivative transactions reported